ASH 2020: Allogeneic Hematopoietic Cell Transplantation Improves Survival in Older Patients With Advanced Myelodysplastic Syndrome
Practice-changing findings will likely expand access to this treatment approach to older populations
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.